Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPHA.1-PROTEINASE INHIBITOR HUMAN for Complement deficiency disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ALPHA.1-PROTEINASE INHIBITOR HUMAN was used for Complement deficiency disease.

Most Reported Side Effects for ALPHA.1-PROTEINASE INHIBITOR HUMAN

Side Effect Reports % Deaths Hosp.
Dyspnoea 1,011 14.2% 57 440
Pneumonia 681 9.6% 71 487
Fatigue 669 9.4% 22 121
Headache 631 8.9% 8 95
Death 456 6.4% 454 108
Cough 447 6.3% 12 168
Product dose omission issue 397 5.6% 45 203
Nausea 385 5.4% 14 90
Malaise 367 5.2% 16 120
Dizziness 314 4.4% 5 63
Pain 287 4.0% 15 96
Pyrexia 270 3.8% 11 103
Covid-19 255 3.6% 20 155
Fall 248 3.5% 30 140
Nasopharyngitis 243 3.4% 8 76

Other Indications for ALPHA.1-PROTEINASE INHIBITOR HUMAN

Alpha-1 antitrypsin deficiency (2,984) Alpha-1 anti-trypsin deficiency (2,937) Product used for unknown indication (591) Emphysema (240) Chronic obstructive pulmonary disease (141) Obstructive airways disorder (39) Asthma (34) Graft versus host disease (26) Immune system disorder (24) Supplementation therapy (24)

Other Drugs Used for Complement deficiency disease

ICATIBANT (338) HUMAN C1-ESTERASE INHIBITOR (59) HUMAN IMMUNOGLOBULIN G (8) AGALSIDASE BETA (6)

Related Pages

ALPHA.1-PROTEINASE INHIBITOR HUMAN Full Profile All Complement deficiency disease Drugs ALPHA.1-PROTEINASE INHIBITOR HUMAN Demographics ALPHA.1-PROTEINASE INHIBITOR HUMAN Timeline